deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01559922

Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

A Phase 3 Randomized Placebo-Controlled Double-Blind Study of the Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

Sponsor: Suneva Medical, Inc.

Conditions Atrophic Acne Scar
Interventions Artefill Normal Saline
Updated 11 times since 2017 Last updated: Oct 21, 2019 Started: Feb 29, 2012 Primary completion: Apr 30, 2013 Completion: Feb 28, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Atrophic Acne Scar and is currently completed. Suneva Medical, Inc. leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshotCompleted~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshotCompleted~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

▶ Show 6 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE3

  2. Dec 2019 — Jan 2021 [monthly]

    Completed PHASE3

  3. Nov 2019 — Dec 2019 [monthly]

    Completed PHASE3

  4. Jun 2018 — Nov 2019 [monthly]

    Completed PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

  6. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE3

    First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Suneva Medical, Inc.
  • ethica Clinical Research Inc.
Data source: Suneva Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations